Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Bulgaria Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20132
20141
20162
20173
20182
20192
20202
20211
20222
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MedImmune LLC3
AbbVie2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Genentech, Inc.2
Alumis Inc1
Amgen1
Biogen1
Boehringer Ingelheim1
Iltoo Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic24
Lupus Erythematosus, Cutaneous4
Connective Tissue Diseases2
Lupus Erythematosus, Discoid2
Autoimmune Diseases1
Immune System Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.